Related Experiment Video
Updated: Dec 29, 2025

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding
Published on: May 1, 2020
Hypertrophic Scarring: Current Knowledge of Predisposing Factors, Cellular and Molecular Mechanisms
Layla Nabai1, Amir Pourghadiri1, Aziz Ghahary1
1BC Professional Firefighters' Burn & Wound Healing Research Laboratory, Department of Surgery, Division of Plastic Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Insights
Hypertrophic scarring (HSc) remains a significant challenge despite medical advances. Understanding the cellular and molecular factors driving HSc is key to developing effective treatments.
Area of Science:
- Dermatology
- Wound Healing
- Fibroproliferative Disorders
Background:
- Hypertrophic scarring (HSc) presents a persistent clinical challenge, impacting millions physically, psychologically, and economically.
- Current preventive and therapeutic strategies for HSc are limited, despite progress in surgical techniques and wound care.
- A deeper understanding of HSc pathophysiology is essential for advancing clinical interventions.
Purpose of the Study:
- To review current knowledge on predisposing factors for hypertrophic scarring.
- To elucidate the cellular and molecular mechanisms underlying hypertrophic scar formation.
- To provide a foundation for developing novel preventive and therapeutic strategies for HSc.
Main Methods:
- Literature review of predisposing factors in hypertrophic scarring.
- Comprehensive analysis of cellular mechanisms in HSc development.
- Detailed examination of molecular pathways involved in fibroproliferative disorders.
Main Results:
- Significant advancements have been made in understanding the cellular and molecular underpinnings of HSc.
- Key predisposing factors contributing to HSc have been identified.
- The review synthesizes current knowledge on the pathophysiology of HSc.
Conclusions:
- Continued research into HSc pathophysiology is critical for improving patient outcomes.
- Elucidating molecular mechanisms offers potential targets for HSc treatment.
- A comprehensive understanding is vital for developing effective HSc prevention and management strategies.
Abstract:
Hypertrophic scarring (HSc) is an age-old problem that still affects millions of people physically, psychologically, and economically. Despite advances in surgical techniques and wound care, prevention and treatment of HSc remains a challenge. Elucidation of factors involved in the development of this common fibroproliferative disorder is crucial for further progress in preventive and/or therapeutic measures. Our knowledge about pathophysiology of HSc at the cellular and molecular level has grown considerably in recent decades. In this article, current knowledge of predisposing factors and the cellular and molecular mechanisms of HSc has been reviewed.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
Clinical Applications of Epidermal Stem Cells
Introduction to Fibroblasts

